ALVO
Alvotech
NASDAQ: ALVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.29
+0.95% today
Updated 2026-09-11
Market cap
$1.86B
P/E ratio
—
P/S ratio
3.76x
EPS (TTM)
$-0.62
Dividend yield
—
52W range
$3 – $9
Volume
0.9M
Alvotech (ALVO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.29
12-Month target
$2.40
2030 Target
$4.64
Intrinsic (DCF)
$17.49
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B | $0.5B | $0.6B | $0.7B | $0.8B | $1.0B | $1.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -36.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.